Shirley Duquene joined Ropes & Gray’s litigation and enforcement practice group in 2021, where she focuses on government enforcement, internal investigations, compliance risk assessments, and post-acquisition compliance integration and monitoring. Shirley has experience advising clients on anti-corruption (including the U.S. Foreign Corrupt Practices Act (FCPA)), international risk, ESG, and other compliance issues. She has assisted clients in investigations and inquires by the U.S. Department of Justice (DOJ), the U.S. Securities and Exchange Commission (SEC), the U.K. Financial Conduct Authority (FCA), the Food and Drug Administration (FDA), and state enforcement agencies. Shirley has worked with a diverse set of companies across the private equity, asset management, manufacturing, health care, education, sports, and hospitality industries.
Shirley is a Certified Information Privacy Professional (CIPP/US). She also maintains a robust pro bono practice, advocating for clients in immigration and housing court.
During law school, Shirley was a student attorney in the Compliance Policy Clinic and the Wrongful Convictions Clinic. She also interned for a Fortune 500 company’s Business & Human Rights team and two human rights non-profit organizations. Prior to law school, Shirley worked as a paralegal at another global law firm in New York and taught English in France.
Experience
- Conducts internal investigations for alleged violations of anti-corruption laws and internal compliance policies involving conduct in Asia, Europe, and the Middle East.
- Supports the Independent FCPA Monitor appointed by the Department of Justice in a three-year monitorship of a commodity trading and mining company, as part of the company’s plea agreement.
- Regularly conducts pre-acquisition and post-acquisition anti-corruption, anti-money laundering, sanctions, and ESG due diligence for large private equity firms and their portfolio companies.
- Provided FCPA and sanctions-related training materials for a multinational company.
- Assisted with data-driven ESG risk assessments for dozens of portfolio companies.
- Conducted a widespread internal investigation for a global sports organization in connection with litigation across numerous jurisdictions.
- Advocated for animal drug wholesaler in a DOJ investigation concerning criminal violations of the Food, Drug, and Cosmetics Act.
- Represented a company in a complex commercial arbitration.
- Advised pharmaceutical company on a DOJ Second Request.
- Represented private equity firms in connection with third party subpoena responses.